Both in Surgical Instruments
Femasys vs NeuroOne Medical Technologies
Over the past year FEMY returned −89.7% and NMTC returned −79.3%; their daily moves had a correlation of 0.00.
FEMY −89.7% NMTC −79.3%Growth of $1, one year, split-adjusted
| Metric | FEMY | NMTC |
|---|---|---|
| Price | $1.36 | $0.9489 |
| Market cap | $11.4M | $8.6M |
| Today | +3.03% | +1.51% |
| 1 month | −32.7% | −14.9% |
| 6 months | −83.0% | −78.6% |
| Year to date | −88.2% | −79.1% |
| 1 year | −89.3% | −80.0% |
| Revenue growth (YoY) | −18.9% | +16.3% |
| Gross margin | 57.1% | 59.9% |
| Net margin | −1346.8% | −101.7% |
| P/E (TTM) | — | — |
| Price / sales | 5.0× | 0.7× |
| Net cash | -$2.1M | $2.0M |
| Dividend yield | — | — |
| Volatility (60d) | 90.2% | 98.7% |
| Short % of float | 2.4% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).